Acta Paediatrica · 2002 · 61 citations · 14 references
MedicinePediatricsPharmacologyClinical PharmacologyPediatric Clinical PharmacologyPediatric PharmacotherapyEssential MedicinesPediatric PharmacologyPharmacoepidemiologyDrug Use AssessmentPediatric Essential Medicines
The study aimed to quantify paediatric off‑label drug use in Italian hospitals and identify priority therapeutic indications for intervention. Prescriptions for all children admitted to nine general paediatric wards between December 1998 and February 1999 were analyzed. Among 4,265 prescriptions for 1,461 children, 60 % were off‑label—affecting 89 % of patients—predominantly antibacterials, antiasthmatics and analgesics, with paracetamol and beclomethasone most common, and dosage/frequency errors accounting for half of off‑label cases, especially in respiratory conditions, underscoring the need for regulatory and evidence‑based interventions.
The aims of the study were to measure the paediatric, off‐label use of drugs in the Italian hospital setting and to reveal areas for priority intervention by investigating the therapeutic indications most involved. Prescriptions given to all children admitted to nine general paediatric hospital wards from December 1998 to February 1999 were analysed. In total, 4265 prescriptions were given to 1461 children, 10 of which were unlicensed and excluded from further analysis. Sixty percent of prescriptions (range between centres: 44‐71%) were off‐label and concerned 89% of children receiving medications (80–96%). The main drug classes were antibacterials, antiasthmatics and analgesics, and represented 56% of off‐label prescriptions. Paracetamol (385 prescriptions) and beclomethasone (339) were the generic substances most often used off‐label. The most common off‐label categories were dosage/frequency (50% of prescriptions), indication and lack of paediatric licence (7% each). Fifty‐four per cent of all indications that led to off‐label prescribing involved only respiratory problems, fever, respiratory tract infections and bronchospasm. Conclusions : Despite prescription profile differences among centres, off‐label use was high everywhere. Immediate action for more rational drug use is necessary and requires not only regulatory intervention but also a more evidence‐based, therapeutic approach.
14
Unlicensed and off label drug use in paediatric wards: prospective study
S. Turner, Aisling Longworth, Anthony J Nunn et al. · BMJ · 1998 · 323 citations · Full text
Risks of Agranulocytosis and Aplastic Anemia
JAMA · 1986 · 305 citations